Welcome to the latest edition of Fenwick’s Securities Law Update. This issue contains updates and important reminders on:
- Form 10-K, Form S-8, and proxy statement disclosures
- The U.S. Court of Appeals for the Fifth Circuit striking down the Nasdaq board diversity disclosure rules
- The Fifth Circuit pausing enforcement of the Corporate Transparency Act
- The U.S. Securities and Exchange Commission publishing its updated Fall 2024 Reg-Flex agenda
- ISS releasing its 2025 Benchmark Voting Policy Updates, including added or updated sections on poison pills, proposals for SPAC extensions, natural capital-related and/or community impact assessment proposals
- Executive security considerations in light of the killing of the UnitedHealthcare CEO